trial

Role Functioning Changes NOS

NCTId NCT02505022
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Terminated
Enrollment 28 (actual)
Sponsored by Northwestern University
Primary completion 2021-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Terminated
Enrollment
28 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2016-01
Primary completion
2021-01
Eligibility
ALL · 18 Years · 26 Years

Interventions & indications

Drugs
PharmacotherapyBehavioral treatment

Sponsors

Northwestern UniversityLead Sponsor

Investigators

1
Will J Cronenwett, MDPrincipal Investigator

Sites

1 total
Chicago, United States

Facts & assertions

4 sourced
Enrollment
28
Phase
NA
Primary Completion Date
2021-01
Status
TERMINATED
relationships
The graph out of here
drug
Pharmacotherapy
drug
Behavioral treatment
drug
lead_sponsor
Northwestern University
company
indication
Bipolar Disorder
indication
Psychotic Disorders
indication
Psychotic Disorders
indication
investigator
Will J Cronenwett, MD
person